Physician profile
Sarah Stanley
NPI 1750995734
$678.70
in general payments reported to CMS, 2019-2025
16 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.77 · 2023: $87.63 · 2024: $243 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.94 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $152.67 | 2022-2023 | Sublocade |
| Seagen INC. | $92.99 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.13 | 2024-2025 | Ninlaro, Alunbrig |
| Gilead Sciences, INC. | $48.80 | 2024 | |
| Pfizer INC. | $47.04 | 2024-2025 | |
| Incyte Corporation | $45.05 | 2024 | Jakafi, Pemazyre, Monjuvi |
| Celgene Corporation | $42.88 | 2025 | Opdivo, Reblozyl |
| Merck Sharp & Dohme LLC | $30.14 | 2024 | Keytruda |
| Braeburn INC. | $27.73 | 2023 | Brixadi |
| Telix Pharmaceuticals | $22.86 | 2025 | Illuccix |
| Adaptive Biotechnologies Corporation | $20.87 | 2024 | Clonoseq |
| Array Biopharma INC | $19.93 | 2025 | Lorbrena, Xalkori, Mektovi |
| Novartis Pharmaceuticals Corporation | $19.28 | 2025 | |
| Adc Therapeutics America, INC. | $17.50 | 2024 | |
| Genentech USA, INC. | $16.01 | 2024 | Lunsumio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.